{"nctId":"NCT00943397","briefTitle":"Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)","startDateStruct":{"date":"2001-04"},"conditions":["Asthma"],"count":190,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: montelukast sodium"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: Usual Care"]}],"interventions":[{"name":"montelukast sodium","otherNames":["Montelukast"]},{"name":"Comparator: Usual Care","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient successfully completed visit 5 of MK0476 Protocol 176 (NCT00943683)\n\nOR:\n\n* Patient is in good, stable health\n* Patient has been fed solid foods for at least 1 month\n* Patients had at least 3 episodes of asthma or asthma-like symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit\n* Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines\n\nExclusion Criteria:\n\n* Patient was hospitalized at the start of the study or had any major surgery 4 weeks prior\n* Patient had an allergy to apples or applesauce","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","maximumAge":"2 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Clinical Adverse Experiences (CAEs) Reported by Patients With up to 52 Weeks of Treatment","description":"An adverse experience (AE) is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the SPONSOR'S product, whether or not considered related to the use of the product","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"156","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":32},"commonTop":["Upper Respiratory Infection","Asthma","Pharyngitis","Otitis Media","Diarrhea"]}}}